Legend Biotech Corporation
LEGN
$34.86
$1.374.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 305.10M | 306.49M | 272.31M | 255.06M | 195.00M |
| Total Other Revenue | -- | -111.00K | 18.00K | 3.00K | 90.00K |
| Total Revenue | 305.10M | 306.38M | 272.33M | 255.06M | 195.00M |
| Cost of Revenue | 261.60M | 224.79M | 228.45M | 196.29M | 173.20M |
| Gross Profit | 43.50M | 81.59M | 43.88M | 58.77M | 21.80M |
| SG&A Expenses | 90.10M | 101.19M | 87.33M | 80.65M | 72.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.20M | 1.00M | -- | -- | 1.00M |
| Total Operating Expenses | 354.90M | 326.98M | 315.78M | 276.94M | 246.70M |
| Operating Income | -49.80M | -20.60M | -43.45M | -21.88M | -51.70M |
| Income Before Tax | -53.10M | -19.60M | -39.07M | -124.80M | -99.20M |
| Income Tax Expenses | 1.20M | 11.22M | 616.00K | 582.00K | 1.80M |
| Earnings from Continuing Operations | -54.30M | -30.82M | -39.69M | -125.38M | -101.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.30M | -30.82M | -39.69M | -125.38M | -101.00M |
| EBIT | -49.80M | -20.60M | -43.45M | -21.88M | -51.70M |
| EBITDA | -47.40M | -17.92M | -41.53M | -19.50M | -49.40M |
| EPS Basic | -0.59 | -0.33 | -0.43 | -1.36 | -1.10 |
| Normalized Basic EPS | -0.18 | -0.07 | -0.13 | -0.42 | -0.34 |
| EPS Diluted | -0.60 | -0.36 | -0.44 | -1.36 | -1.10 |
| Normalized Diluted EPS | -0.18 | -0.07 | -0.13 | -0.42 | -0.34 |
| Average Basic Shares Outstanding | 185.10M | 184.73M | 184.64M | 184.14M | 183.75M |
| Average Diluted Shares Outstanding | 92.55M | 92.37M | 92.32M | 92.07M | 91.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |